Tomorrow’s World in Medicines
To address the potential medicines of tomorrow, a panel of experts will discuss emerging therapies and the potential of developing new medicines and repurposing old medicines on Tuesday Nov. 5, 2019 at CPhI in Frankfurt, Germany.
Emerging therapeutic areas, such as oncology, cardiovascular, autoimmune, pulmonary, and mental health, are becoming more and more important for pharma companies. These conditions often encompass complex and difficult disease processes that can require individualized treatment.
To address the potential medicines of tomorrow, a panel of experts will discuss emerging therapies and the potential of developing new medicines and repurposing old medicines on Tuesday Nov. 5, 2019 at CPhI in Frankfurt, Germany. Some of the topics for consideration will be value added medicines, personalized therapies, the market shift towards niche therapies, and the future of generics.
The panel of experts participating in the discussion will be Aurelio Arias (IQVIA), Subodh Deshmukh (Sandoz), Ken Phelps (Camargo Pharmaceutical Services), Dr. Thomas Solbach (Strategy&), Paul Thorning (Crystec Pharma), and Dr. Andreas Wicki (KSBL).
The Future of Medicine: What are the therapies of tomorrow?Tuesday Nov. 5, 201910:30–11:40CPhI Theatre (61D61)
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Shilpa Medicare Launches ‘Hybrid CDMO’ at DCAT Week 2025
March 17th 2025This model is being positioned by Shilpa as a dual approach that offers comprehensive discovery, clinical, and commercial outsourcing services in addition to commercially ready, “off-the-shelf” novel formulations for b2b licensing.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
